News & Events

Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending

Capital Funding for Diagnostic Ultrasound Companies Normalises After 2018 Spike

27th February 2020 – Written by Mustafa  Hassan – Featured on HealthTech Hotspot – Capital investment in diagnostic ultrasound companies reached a record breaking $390 million in 2018. This was due to the $250 million Series D funding raised by Butterfly Network and the $73 million pre-turn Series A funding raised by Aisono.  This trend did […]

Is Teleradiology’s Growth Sustainable Beyond 2020?

03rd March 2020 – Written by Arun Gill – Featured on AuntMinnie Europe – Demand for diagnostic imaging is increasing each year. The volume of examinations in the U.K and Ireland reached 50.7 million in 2018 — a rise of 1.7% versus 2017 — of which x-ray accounted for over half of overall demand by […]

From lab to clinic : How AI can help

2nd March 2020 – By Ulrik Kristensen, PhD, The Science Advisory Board contributing writer – Featured on The Science Advisory Board – Artificial intelligence (AI) and machine learning are becoming essential for biomedical research. From analyzing real-world data and scientific information to providing improved predictive outcomes, clinical trials are an important checkpoint in moving therapies from […]

Three High Impact AI Market Trends in Medical Imaging at RSNA 2019

11th February 2020 – Written by Sanjay M. Parekh PhD – Featured on Diagnostic and Interventional Cardiology – At the 2019 Radiological Society of North America (RSNA) meeting in December, there was a record number of artificial intelligence (AI) vendors exhibiting at the conference. The large number prompting the RSNA to create a third exhibit […]

Hg Capital Acquires Majority Stake in Intelerad: The Signify View

10th February 2020 – Written by Steve Holloway – Featured on Healthcare Business Euro News – After a relatively short search, Intelerad has found a new majority stakeholder, Hg Capital.  The London, UK-based investment firm has already invested over $1B in the healthcare and life sciences sector, including firms such as Rhapsody and Corepoint (healthcare […]